We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
24 hedge funds and large institutions have $3.29M invested in CASI Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
0% more funds holding
Funds holding: 24 → 24 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.85% less ownership
Funds ownership: 14.61% → 13.76% (-0.85%)
36% less capital invested
Capital invested by funds: $5.17M → $3.29M (-$1.88M)
Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$227K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$29K |
| 3 |
WSCM
Wellington Shields Capital Management
New York
|
-$24K |
| 4 |
Morgan Stanley
New York
|
-$4.03K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.31K |
